AstraZeneca partnership to pioneer UK’s first commercial biomethane supply
European Pharmaceutical Review
SEPTEMBER 14, 2023
The pharmaceutical firm is investing greatly in its existing infrastructure to facilitate the shift to renewable gas and support a transition to 100 percent renewable energy. Alongside this move, AstraZeneca’s investment in major energy efficiencies in its operations, brings the total of its financial commitment to net zero, to £100 million.
Let's personalize your content